Dovitinib, CAS [[405169-16-6]]
Artikelnummer:
MCE-HY-50905
| Artikelname: |
Dovitinib, CAS [[405169-16-6]] |
| Artikelnummer: |
MCE-HY-50905 |
| Hersteller Artikelnummer: |
HY-50905 |
| Alternativnummer: |
MCE-HY-50905-10MMX1ML,MCE-HY-50905-100MG,MCE-HY-50905-50MG,MCE-HY-50905-10MG,MCE-HY-50905-25MG,MCE-HY-50905-5MG |
| Hersteller: |
MedchemExpress |
| Kategorie: |
Biochemikalien |
| Alternative Synonym: |
CHIR-258, TKI258 |
| Dovitinib (CHIR-258) is an orally active, potent multi-targeted tyrosine kinase (RTK) inhibitor with IC50s of 1, 2, 36, 8/9, 10/13/8, 27/210 nM for FLT3, c-Kit, CSF-1R, FGFR1/FGFR3, VEGFR1/VEGFR2/VEGFR3 and PDGFRalpha/PDGFRbeta, respectively. Dovitinib has potent antitumor activity[1][2]. |
| Molekulargewicht: |
392.43 |
| Reinheit: |
99.88 |
| CAS Nummer: |
[405169-16-6] |
| Formel: |
C21H21FN6O |
| Target-Kategorie: |
c-Fms,c-Kit,FGFR,FLT3,PDGFR,VEGFR |
| Anwendungsbeschreibung: |
MCE Product type: Reference compound |
